Axxam vs PozeSCAF Inc.

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/axxam/pozescaf-discovery-solutions

Category	Axxam	PozeSCAF Inc.
Listed site	cro	cro
Summary	Contract research organization specializing in integrated drug discovery services, from target validation to hit and lead identification across therapeutic areas.	Preclinical drug discovery CRO combining proprietary generative AI platform AxDrug with computational chemistry, synthetic chemistry, and in vitro biology to accelerate hit discovery and lead optimization for biotech and pharma clients.
Services	Target Identification & Validation Discovery Research High-Throughput Screening In Vitro Pharmacology In Vitro ADME / DMPK Preclinical In Vitro Studies	Computational & In-Silico Drug Discovery Target Identification & Validation High-Throughput Screening Medicinal Chemistry Discovery Research
Modalities	Data not yet provided.	Small Molecule Peptide Antibody-Drug Conjugate (ADC)
Indications	Data not yet provided.	Data not yet provided.
Locations	Headquarters and laboratories, Bresso, Milan, Italy Laboratories, Torre Annunziata, Naples, Italy Business development office, Cambridge, Massachusetts, USA Business development office, Copenhagen, Denmark Business development office, Basel, Switzerland	Data not yet provided.
Certifications	ISO · Identifier: ISO 9001:2015 ISO · Identifier: ISO 45001:2018 ISO · Identifier: ISO/IEC 27001:2024	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.